Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas

被引:6
|
作者
Meneses-García A. [1 ]
Betancourt A.M. [1 ]
Abarca J.H. [2 ]
Montes A.B. [2 ]
Roa L.S. [1 ]
Ruíz-Godoy L. [3 ]
机构
[1] Pathology Department, Instituto Nacional de Cancerología
[2] Pharmacology Department, Instituto Politécnico Nacional
[3] Basic Research, Instituto Nacional de Cancerología
关键词
Nasal Cavity; Neoplastic Cell; Blood Vessel Wall; Extranodal Lymphoma; Cytotoxic Granule;
D O I
10.1186/1477-7819-6-114
中图分类号
学科分类号
摘要
Background: Extranodal T/NK cell lymphomas possess distinctive clinico-pathological characteristics: they are angiocentric, exhibit extensive necrosis. Prognosis is poor in the short term. The objective is to explore the expression of different MMPs in the cells and stroma which are around of the blood vessels damaged and their correlation with clinico-pathological parameters. Patients and methods: Twenty cases of this type of lymphomas were studied and collected patient clinical data. The expressions of MMP-1, 2, 3, 9, 11, 13 and TIMP-1, 2 were studied by immunohistochemistry. Ultrastructural studies were performed in two cases. Statistical analysis was done with Fisher's exact test, Chi2 test. Results: Of the 20 patients, 13 were men with median age of 43 years. In 13 patients the primary tumor was localized in the nasal cavity. Treatment was combined chemotherapy and radiotherapy in 60%. The 55% advanced clinical stages, 70% died from the disease. There were neoplastic cell and peritumoral fibroblasts positivity to MMP-1 and MMP-11 in most of the cases. The MMPs-2, 3 and 9 were expressed in neoplastic cell between 30 to 65%of the cases. TIMP-1 was presented mainly in the epithelium and TIMP-2 was poor expressed of the all cases. Conclusion: There were no statistical significance between the different enzymes used and the clinical parameters, besides status and survival of the patients. It is necessary to study more enzymes and focus them to quantify and determine their activity, in order to have a better correlation with histological features in this type of neoplasm. © 2008 Meneses-García et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [41] The expression of matrix metalloproteinase (MMP)-2, MMP-9, tissue inhibitor of MMP (TIMP)-1 and TIMP-2 in adenoma and adenocarcinoma of the gallbladder
    Bae, JY
    Choi, J
    Chung, HC
    Park, C
    Park, YN
    LABORATORY INVESTIGATION, 2003, 83 (01) : 271A - 271A
  • [42] THE CLINICAL SIGNIFICANCE OF TIMP-1, TIMP-2, MMP-2, MMP-9, OSTEOPROTEGERIN, SRANKL, AND ISS IN MULTIPLE MYELOMA PATIENTS
    Oliveira, L. C.
    Uzielli, J. A.
    Baggio, M. S.
    Lange, A. P.
    Tanus-Santos, J. E.
    Rego, E. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 389 - 389
  • [43] The expression of matrix metalloproteinase (MMP)-2, MMP-9, tissue inhibitor of MMP (TIMP)-1 and TIMP-2 in adenoma and adenocarcinoma of the gallbladder
    Bae, JY
    Choi, J
    Chung, HC
    Park, C
    Park, YN
    MODERN PATHOLOGY, 2003, 16 (01) : 271A - 271A
  • [44] The gelatinases MMP-2, MMP-9 and their inhibitors TIMP-1, TIMP-2 are constitutively expressed by uterine natural killer cells
    Bianco, J. E. R.
    Rosa, R. G.
    Lippe, E. M.
    Joazeiro, P. P.
    Yamada, A. T.
    PLACENTA, 2008, 29 (01) : 112 - 112
  • [45] Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with Graves' orbitopathy
    Kapelko-Slowik, Katarzyna
    Slowik, Miroslaw
    Szalinski, Marek
    Dybko, Jaroslaw
    Wolowiec, Dariusz
    Prajs, Iwona
    Bohdanowicz-Pawlak, Anna
    Biernat, Monika
    Urbaniak-Kujda, Donata
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (01): : 99 - 103
  • [46] 人食管鳞癌组织中MMP-2、MMP-9和TIMP-1、TIMP-2的表达
    温洪涛
    张蕾
    李继昌
    张云汉
    郑州大学学报(医学版), 2006, (03) : 418 - 420
  • [47] Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate
    Limaye, Anil M.
    Desai, Kartiki V.
    Chavalmane, Aravinda K.
    Kondaiah, Paturu
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 294 (1-2) : 10 - 18
  • [48] Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes
    Toth, M
    Chvyrkova, I
    Bernardo, MM
    Hernandez-Barrantes, S
    Fridman, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (02) : 386 - 395
  • [49] Urinary Levels of Matrix Metalloproteinases (MMP-1 and MMP-2) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Proteinuric Children
    Korzeniecka-Kozerska, A.
    Wasilewska, A.
    Taranta-Janusz, K.
    Zoch-Zwierz, W. M.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1871 - 1871
  • [50] Circulating MMP-9, TIMP-1 and TIMP-2 in gestational hypertension
    Tayebjee, MH
    Karalis, I
    Nadar, SK
    Beevers, DG
    MacFadyen, RJ
    Lip, GY
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 162A - 163A